An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 3, 1999, Pages 329-337

  Raengsakulrach, Boonyos ^a   Nisalak, Ananda ^a   Gettayacamin, Montip ^a   Thirawuth, Vipa ^a   Young, G David ^b   Myint, Khin Saw Aye ^a   Ferguson, Laura M ^c   Hoke Jr , Charles H ^d   Innis, Bruce L ^e   Vaughn, David W ^e  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^c Pasteur Merieux Connaught   (United States)

^d Medical Research and Materiel Command   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EJN 058; IMMUNOGLOBULIN M; JAPANESE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS VIRUS; MALE; NONHUMAN; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; VALIDATION PROCESS; VIREMIA; VIRUS CULTURE; VIRUS ENCEPHALITIS; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALIA; JAPANESE ENCEPHALITIS VIRUS; MACACA MULATTA;

EID: 0032908983     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.329     Document Type: Article

References (33)

1. Vaughn DW, Hoke CH Jr, 1992. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14: 197-221.
2. Tsai TF, Yu YX, 1994. Japanese encephalitis vaccines. Plotkin SA, Mortimer EA, eds. Vaccines. Second edition. Philadelphia: W. B. Saunders, 671-713.
3. Innis BL, 1995. Japanese encephalitis. Porterfield JS, ed. Kass Handbook of Infectious Diseases: Exotic Viral Infections. London: Chapman & Hall Medical, 147-174.
4. Ho-Min L, 1986. Studies on attenuated live JE virus vaccine. Fukai K, ed. Virus Vaccines in Asian Countries. Tokyo: University of Tokyo Press, 159-165.
5. 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6: 513-518.
6. 14-14-2) for children. Am J Trop Med Hyg 39: 214-217.
7. Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, Burke DS, 1988. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608-614.
8. Andersen MM, Rrnne T, 1991. Side-effects with Japanese encephalitis vaccine. Lancet 337: 1044.
9. Ruff TA, Eisen D, Fuller A, Kass R, 1991. Adverse reactions to Japanese encephalitis vaccine. Lancet 338: 881-882.
10. Robinson HC, Russell ML, Csokonay WM, 1991. Japanese encephalitis vaccine and adverse effects among travellers. Can Dis Wkly Rep 17: 173-174, 177.
11. Nazareth B, Levin J, Johnson H, Begg N, 1994. Systemic allergic reactions to Japanese encephalitis vaccines. Vaccine 12: 666.
12. Ohtaki E, Matsuishi T, Hirano Y, Maekawa K, 1995. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains). J Neurol Neurosurg Psychiatry 59: 316-317.
13. Plesner A, Arlien-Srborg P, Herning M, 1996. Neurological complications and Japanese encephalitis vaccination. Lancet 348: 202-203.
14. Konishi E, Pincus S, Paoletti E, Laegreid WW, Shope RE, Mason PW, 1992. A highly attenuated host range-restricted vaccinia virus strain. NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 190: 454-458.
15. Konishi E, Pincus S, Paoletti E, Shope RE, Mason PW, 1994. Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12: 633-638.
16. Harrington DG, Hilmas DE, Elwell MR, Whitmire RE, Stephen EL, 1977. Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly(I)-poly(C). Am J Trop Med Hyg 26: 1191-1198.
17. Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young GD, Myint KSA, Ferguson LM, Hoke CH Jr. Innis BL, Vaughn DW, 1999. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 60: 343-349.
18. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH, 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am J Trop Med Hyg 40: 418-427.
19. Clarke DH, Casals J, 1958. Techniques for hemagglutination and hemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561-573.
20. Russell PK, Nisalak A, Sukhavachana P, Vivona S, 1967. A plaque reduction test for dengue virus neutralization antibodies. J Immunol 99: 285-290.
21. Kuno G, Gubler DJ, Santiago de Weil N, 1985. Antigen capture ELISA for the identification of dengue viruses. J Virol Methods 12: 93-103.
22. Chomczynski P, Sacchi N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
23. Myint KSA, Raengsakulrach B, Young GD, Gettayacamin M, Ferguson LM, Innis BL, Hoke CH Jr, Vaughn DW, 1999. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg 60: 338-342.
24. Miura T, 1970. A new method for a potency test of Japanese encephalitis vaccine. Direct challenge method on suckling mice by subcutaneous inoculation. Bull World Health Org 43: 553-557.
25. Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K, 1990. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol 64: 2788-2795.
26. Mason PW, Pincus S, Fournier MJ, Mason TL, Shope RE, Paoletti E, 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180: 294-305.
27. Lee HW, Scherer WF, 1961. The anamnestic antibody response to Japanese encephalitis virus in monkeys and its implications concerning naturally acquired immunity in man. J Immunol 86: 151-164.
28. Imam IZE, Hammon WM, 1957. Challenge of monkeys with Japanese B virus after immunization by West Nile infection plus Japanese B vaccine. J Immunol 79: 253-257.
29. Zhang M, Wang M, Jiang S, Ma W, 1989. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J Med Virol 29: 133-138.
30. Lee GC, Grayston JT, Wang S, 1967. Protective studies in mice and monkeys with an inactivated Japanese encephalitis virus vaccine grown in hamster diploid cell culture. Proc Soc Exp Biol Med 125: 803-808.
31. Ghosh SN, Goverdhan MK, Sathe PS, Chelliah SC, Naik SV, Godbole PV, Banerjee K, 1990. Protective effect of 6-MFA, a fungal interferon inducer against Japanese encephalitis virus in bonnet macaques. Indian J Med Res 91: 408-413.
32. Leake CJ, Burke DS, Nisalak A, Hoke CH, 1986. Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. Am J Trop Med Hyg 35: 1045-1050.
33. Kumar R, Mathur A, Kumar A, Sharma S, Saksena PN, Chaturvedi UC, 1988 Japanese encephalitis - an important cause of acute childhood encephalopathy in Lucknow, India. Post-grad Med J 64: 18-22.